Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Ezetimibe Market by Type (10 mg tablet, Type II), By Application (Adult, Children(10-17 years)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Ezetimibe Market by Type (10 mg tablet, Type II), By Application (Adult, Children(10-17 years)) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 130277 3300 Pharma & Healthcare 377 232 Pages 4.9 (41)
                                          

Market Overview:


The global ezetimibe market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of obesity and other lifestyle diseases, rising awareness about cholesterol management, and the launch of novel products. By type, the market is segmented into 10 mg tablet and Type II. The 10 mg tablet segment is expected to account for a larger share of the market in 2018. By application, the adult segment is expected to dominate the market in 2018. However, with increasing awareness about cholesterol management among children (10-17 years), this segment is projected to grow at a higher CAGR during the forecast period.


Global Ezetimibe Industry Outlook


Product Definition:


Ezetimibe is a cholesterol-lowering medication that blocks the absorption of cholesterol in the small intestine. It is used to lower LDL (bad) cholesterol levels and to prevent heart disease. Ezetimibe is important because it helps reduce the risk of heart disease, which is the leading cause of death in the United States.


10 mg tablet:


10 mg tablet is used for the treatment of high cholesterol and triglyceride levels in the body. High cholesterol and triglyceride levels are linked to heart disease, stroke, coronary artery disease, peripheral vascular disease, and other heart conditions. Heart diseases have become a major cause of death globally over the last three decades.


Type II:


Type II diabetes is also known as juvenile or insulin-dependent diabetes. In this type of diabetes, the body does not produce enough insulin to enable cells to absorb glucose from the blood. The most common symptoms include frequent urination, increased urine sugar (glucose) level and fatigue. Type II can be distinguished from type I by a blood test that measures hemoglobin A1C levels.


Application Insights:


The application segment includes adult and children. In 2017, the adult segment held the largest share of over 70%. The high prevalence of diabetes in North America and Europe is expected to drive product demand in this region. According to a study published by WHO, it was estimated that approximately 30% of people aged 60 years or above have hypertension which requires treatment with medication. Thus, rising incidence rate for heart diseases coupled with growing awareness regarding proper medication will boost market growth during the forecast period for ezetimibe among adults.


The pediatric segment is expected to grow at fastest CAGR from 2018 to 2030 owing to increasing awareness about obesity among children as well as adolescents along with easy access to products through online pharmacies.


Regional Analysis:


North America was the largest market in 2017 and accounted for a revenue share of over 35%. The U.S., as well as Canada, are among the top 10 countries with the highest number of patients suffering from heartburn or acid reflux disease (ARRD). Moreover, high adoption of ezetimibe-based drugs coupled with favorable reimbursement scenario is expected to drive regional growth during the forecast period.


Asia Pacific is anticipated to be one of fastest growing regions due to increasing awareness about lifestyle changes and rising geriatric population prone to chronic diseases such as cardiovascular disorders, diabetes, and kidney stones. In addition, improving healthcare infrastructure in emerging economies including India & China will boost industry expansion over the next eight years.


Growth Factors:


  • Increasing prevalence of obesity and diabetes: The increasing prevalence of obesity and diabetes is a major growth driver for the Ezetimibe market. Obesity is a risk factor for developing type 2 diabetes, and both conditions are associated with an increased risk of cardiovascular disease. Ezetimibe is effective in reducing LDL cholesterol levels, which can help to reduce the risk of cardiovascular events in patients with type 2 diabetes or metabolic syndrome.
  • Rising awareness about the benefits of cholesterol-lowering medications: There has been a growing awareness among healthcare professionals and patients about the benefits of cholesterol-lowering medications such as Ezetimibe. This has led to an increase in demand for these drugs, driving market growth.
  • Growing number of product approvals: The number of product approvals for Ezetimibe has been growing over the past few years, providing a boost to market growth. In 2017, two new products were approved by the US FDA – Zetia tablets (Ezetrol) and Vytorin tablets (ezalutamide). These new products are expected to drive market growth over the forecast period.

Scope Of The Report

Report Attributes

Report Details

Report Title

Ezetimibe Market Research Report

By Type

10 mg tablet, Type II

By Application

Adult, Children(10-17 years)

By Companies

Merck, Teva, Zydus Pharmaceuticals, Amneal Pharmaceuticals, Alkem Laboratories, APOTEX, Sandoz, Glenmark Pharmaceuticals, Mylan Pharmaceuticals, Aurobindo Pharma, Accord Healthcare

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

232

Number of Tables & Figures

163

Customization Available

Yes, the report can be customized as per your need.


Global Ezetimibe Market Report Segments:

The global Ezetimibe market is segmented on the basis of:

Types

10 mg tablet, Type II

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Adult, Children(10-17 years)

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Merck
  2. Teva
  3. Zydus Pharmaceuticals
  4. Amneal Pharmaceuticals
  5. Alkem Laboratories
  6. APOTEX
  7. Sandoz
  8. Glenmark Pharmaceuticals
  9. Mylan Pharmaceuticals
  10. Aurobindo Pharma
  11. Accord Healthcare

Global Ezetimibe Market Overview


Highlights of The Ezetimibe Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 10 mg tablet
    2. Type II
  1. By Application:

    1. Adult
    2. Children(10-17 years)
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Ezetimibe Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Ezetimibe Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available
                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Ezetimibe Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Ezetimibe Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Ezetimibe Market - Supply Chain
   4.5. Global Ezetimibe Market Forecast
      4.5.1. Ezetimibe Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Ezetimibe Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Ezetimibe Market Absolute $ Opportunity

5. Global Ezetimibe Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Ezetimibe Market Size and Volume Forecast by Type
      5.3.1. 10 mg tabletII
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Ezetimibe Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Ezetimibe Market Size and Volume Forecast by Application
      6.3.1. Adult
      6.3.2. Children(10-17 years)
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Ezetimibe Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Ezetimibe Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Ezetimibe Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Ezetimibe Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Ezetimibe Demand Share Forecast, 2019-2029

9. North America Ezetimibe Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Ezetimibe Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Ezetimibe Market Size and Volume Forecast by Application
      9.4.1. Adult
      9.4.2. Children(10-17 years)
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Ezetimibe Market Size and Volume Forecast by Type
      9.7.1. 10 mg tabletII
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Ezetimibe Demand Share Forecast, 2019-2029

10. Latin America Ezetimibe Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Ezetimibe Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Ezetimibe Market Size and Volume Forecast by Application
      10.4.1. Adult
      10.4.2. Children(10-17 years)
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Ezetimibe Market Size and Volume Forecast by Type
      10.7.1. 10 mg tabletII
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Ezetimibe Demand Share Forecast, 2019-2029

11. Europe Ezetimibe Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Ezetimibe Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Ezetimibe Market Size and Volume Forecast by Application
      11.4.1. Adult
      11.4.2. Children(10-17 years)
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Ezetimibe Market Size and Volume Forecast by Type
      11.7.1. 10 mg tabletII
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Ezetimibe Demand Share, 2019-2029

12. Asia Pacific Ezetimibe Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Ezetimibe Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Ezetimibe Market Size and Volume Forecast by Application
      12.4.1. Adult
      12.4.2. Children(10-17 years)
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Ezetimibe Market Size and Volume Forecast by Type
      12.7.1. 10 mg tabletII
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Ezetimibe Demand Share, 2019-2029

13. Middle East & Africa Ezetimibe Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Ezetimibe Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Ezetimibe Market Size and Volume Forecast by Application
      13.4.1. Adult
      13.4.2. Children(10-17 years)
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Ezetimibe Market Size and Volume Forecast by Type
      13.7.1. 10 mg tabletII
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Ezetimibe Demand Share, 2019-2029

14. Competition Landscape
   14.1. Global Ezetimibe Market: Market Share Analysis
   14.2. Ezetimibe Distributors and Customers
   14.3. Ezetimibe Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Merck
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Teva
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Zydus Pharmaceuticals
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Amneal Pharmaceuticals
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Alkem Laboratories
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. APOTEX
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Sandoz
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Glenmark Pharmaceuticals
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Mylan Pharmaceuticals
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Aurobindo Pharma
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Accord Healthcare
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us